Clinical Trials

25 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT07460726 2026-03-10

PRIAPUS-PCa

130 enrolled

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

NCT07454603 2026-03-06

PROSTest_STRAT

1,500 enrolled

Disease, Prostatic Neoplasms

NCT07455058 2026-03-06

VAPOR-LTR

2,500 enrolled

Prostatic Neoplasms

NCT07437482 2026-03-03

CLEAR-PC

3,100 enrolled

Disease, Prostatic Neoplasms

NCT06987045 2026-02-27

TransPRIDE

Prostatic Neoplasms

NCT07332832 2026-02-18

SEQ-bpMRI

1,000 enrolled

Prostatic Neoplasms

NCT07407686 2026-02-12

INCLUDE PC

100 enrolled

Prostatic Neoplasms

NCT07376057 2026-01-29

Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer

150 enrolled

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT07004582 2026-01-27

PR3DICT

600 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT07344779 2026-01-26

ROAD

1,600 enrolled

Prostatic Neoplasms

NCT07112612 2026-01-12

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

50 enrolled

Prostatic Neoplasms, Neoplasm, Residual

NCT07237399 2025-12-26

TA-P-OLIM

50 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06637943 2025-12-08

Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy

GastrointestinalGenitourinary

210 enrolled

Aortic Diseases, Liver Neoplasms, Prostatic Neoplasms, Thrombosis, Myocardial Ischemia

NCT07264088 2025-12-04

FOLLOW-UP

100,000 enrolled

Prostatic Neoplasms

NCT07144228 2025-11-25

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

300 enrolled

Disease, Prostatic Neoplasms

NCT07208292 2025-10-06

RWS-GU001

115 enrolled

Prostatic Neoplasms

NCT06773806 2025-09-19

CHLOECAPA

3,600 enrolled

Prostatic Neoplasms

NCT06355050 2025-09-08

ultraHART

150 enrolled

Prostatic Neoplasms

NCT06607783 2025-08-28

PREDICT

66 enrolled

Disease, Prostatic Neoplasms

NCT06672926 2025-08-27

NEWPROMRI

1,600 enrolled

Prostatic Neoplasms

NCT07096596 2025-07-31

PROSPEX

3,000 enrolled

Neoplasms, Prostatic Neoplasms

NCT06194461 2025-06-27

LOCUS

GastrointestinalGenitourinary

64 enrolled

Carcinoma, Hepatocellular, Prostatic Neoplasms

NCT06815055 2025-06-05

PREduKiné

510 enrolled

Prostatic Neoplasms

NCT06298838 2025-05-01

High-resolution Intra-operative PSMA PET-CT in Prostate Cancer

10 enrolled

Prostatic Neoplasms

NCT06916013 2025-04-08

Focal Laser Ablation in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT06900348 2025-03-30

Prostate Specific Antigen Levels of Individuals Living in Rural Areas

308 enrolled

Prostatic Neoplasms

NCT06838520 2025-02-20

Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer

200 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06772116 2025-01-13

JR

1,000 enrolled

Prostatic Neoplasms

NCT06762925 2025-01-08

Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment

450 enrolled

Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms

NCT06608225 2024-11-29

Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy

100 enrolled

Prostatic Neoplasms

NCT06707974 2024-11-27

Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy

100 enrolled

Prostatic Neoplasms

NCT06524219 2024-08-19

Comparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery.

150 enrolled

Prostatic Neoplasms

NCT06489496 2024-07-08

PAX

1,000 enrolled

Prostatic Neoplasms

NCT06469710 2024-06-24

A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients

50 enrolled

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT06435702 2024-05-30

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

108 enrolled

Prostatic Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Prostatic Neoplasms

NCT06366308 2024-04-16

Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population

10,000 enrolled

Prostatic Neoplasms

NCT05411354 2024-01-02

Analyzing Clinical Trial Experiences of Prostate Cancer Patients

400 enrolled

Prostatic Neoplasms

NCT06145958 2023-11-24

RADICALS-TR

2,585 enrolled

Prostatic Neoplasms

NCT06070272 2023-10-06

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Prostatic Neoplasms

NCT06009549 2023-08-24

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients